Raymond James lowered the firm’s price target on Thermo Fisher (TMO) to $525 from $667 and keeps an Outperform rating on the shares. Thermo Fisher reported slightly better revenues and EPS for Q1, but weaker margins, and guidance was lower on macro factors, the analyst tells investors in a research note. The firm thinks current levels represent an attractive entry point.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher’s Strategic Resilience Amidst Economic Challenges: A Buy Recommendation
- Thermo Fisher to invest $2B in U.S. manufacturing
- Thermo Fisher price target lowered to $620 from $665 at Stifel
- Thermo Fisher price target lowered to $637 from $651 at RBC Capital
- Thermo Fisher price target lowered to $573 from $603 at Baird